Home / Japan / Chiome Bioscience Inc.
Chiome Bioscience Inc.
Short position disclosed on September 16, 2026.
1.18% of the capital sold short
1 disclosing fund
35 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Aug 12Aug 21Aug 30Sep 8Sep 17
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Barclays Capital Securities Ltd | 1.18% | +0.58 pt | September 16, 2026 |
Get the moves on Chiome Bioscience Inc. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 35 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 12.36% of the capital sold short
- Towa Corporation 10.49% of the capital sold short
- TESS Holdings Co.,Ltd. 6.97% of the capital sold short
- Unitika LTD. 6.96% of the capital sold short
- Jibannet Holdings Co.,Ltd. 6.90% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.52% of the capital sold short
- Toyo Engineering Corporation 6.29% of the capital sold short
- JSH Co.,Ltd. 5.97% of the capital sold short
- Datasection Inc. 5.83% of the capital sold short
- Def consulting,inc. 5.76% of the capital sold short
- Tri Chemical Laboratories Inc. 5.71% of the capital sold short
- Toho Zinc Co.,Ltd. 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Chiome Bioscience Inc., source JPX, data as at September 16, 2026, https://www.quivad.com/action/chiome-bioscience-inc